Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Jupiter Wellness, Inc.

CORRECTION FROM SOURCE: Jupiter Wellness Developing Novel Women's Sexual Health Product
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers JUPW
Jupiter Wellness Developing Novel Women’s Sexual Health Product
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers JUPW
Jupiter Wellness Expands Distribution in Asia and the Middle East with Newly Acquired Minoxidil (Rogaine(R)) and Photoci(TM) Products
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness Licenses Minoxidil Booster to Taisho
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Dr. Andy Goren and Dr. John McCoy Appointed to Senior Scientific Positions at Jupiter Wellness
From Jupiter Wellness, Inc.
Via AccessWire
Exposures COVID-19
Tickers JUPW
Jupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science
From Jupiter Wellness, Inc.
Via AccessWire
Exposures COVID-19
Tickers JUPW
Paul Jones Appointed as Senior Project Manager at Jupiter Wellness
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness' to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness to Offer Clinical Research Services with Acquisition of Ascent Clinical Research: $3 Million Annual Revenue & EBITDA Contribution to Jupiter
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness Appoints E-Commerce & Marketing Team to Drive Sales of its Growing Portfolio of Proprietary Health and Wellness Brands
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness to Launch CaniSun for Shark Defense Sunscreen with Patented Shark Repellents
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Article "Novel Cannabidiol Aspartame Combination Treatment (JW-100) Significantly Reduces ISGA Score in Atopic Dermatitis: Results From a Randomized Double-Blinded Placebo-Controlled Interventional Study" Published in Journal of Cosmetic Dermatology
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness Launches NoStingz Jellyfish Protective Sunscreen Backed by Patent-Pending Formula in $13 B Sunscreen Market
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers JUPW
Jupiter Wellness Completes Enrollment in Double-Blind Placebo-Controlled Clinical Trial of JW-200 for the Treatment of Actinic Keratosis
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness Merger Partner Next Frontier's Executive Chairman Shannon Soqui Interview with Benzinga
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness’ CEO Brian John & Next Frontier’s Executive Chairman Shannon Soqui Interviewed on SNN Network
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Announces Plans for Oral Dronabinol Solution for the Treatment of Alzheimer's Disease Agitation
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Tickers JUPW
Jupiter Wellness Announces Board Approval of $5.0 Million Share Buyback Program
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness to Dividend SRM Entertainment Subsidiary to its Stockholders
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development and API Market
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Tickers CSE:GWS GWSFF JUPW
Jupiter Wellness Issues Letter to Stockholders
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals, a Leading Drug Developer and Manufacturer of Synthetic Cannabinoid Pharmaceuticals
From Jupiter Wellness, Inc.
Via AccessWire
Topics Cannabis Intellectual Property Regulatory Compliance
Exposures Cannabis Intellectual Property Legal
Tickers JUPW
Jupiter Wellness Announces JW-300 Clinical Trial Results
From Jupiter Wellness, Inc.
Via AccessWire
Tickers JUPW
Jupiter Wellness Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Tickers JUPW
Jupiter Wellness Sponsors Jupiter Wellness Acquisition Corp SPAC Targeting AI Medical Therapeutics and Diagnostics
From Jupiter Wellness, Inc.
Via AccessWire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers JUPW
Jupiter Wellness Announces First Patient Dosing for Double-Blinded Placebo Controlled Trial of JW-300 for the Treatment of First Degree Burns
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers JUPW
Jupiter Wellness Provides Shareholder Update on Multiple Clinical & Commercial Milestones
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Tickers JUPW
Jupiter Wellness Announces Multi-Year Extension of Endorsement Agreement with Pro Golfer Ernie Els
From Jupiter Wellness, Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers JUPW
Jupiter Wellness Submitted a Pre-IND Meeting Request with the US FDA for its Proposed Clinical Program of JW-100 as a Treatment for Mild to Moderate Eczema
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Tickers JUPW
Jupiter Wellness Applies for IND number from the US Food and Drug Administration
From Jupiter Wellness, Inc.
Via AccessWire
Exposures Product Safety
Tickers JUPW
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.